The BMJ reports that renewed concerns about the “revolving door” between government and industry have been sparked by the health minister of England’s decision to join to drug company Roche.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.